These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 198893)

  • 1. [Bismuth treatment and blood bismuth levels].
    Hillemand P; Pallière M; Laquais B; Bouvet P
    Sem Hop; 1977 Sep; 53(31-32):1663-9. PubMed ID: 198893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relationship between the course of bismuth encephalopathy and the amount of bismuth in blood and urine].
    Boiteau HL; Cler JM; Mathé JF; Delobel R; Fève J
    Eur J Toxicol Environ Hyg; 1976; 9(4):233-9. PubMed ID: 976332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [20 cases of acute encephalopathy with myoclonus during treatments with orally-administered bismuth salts].
    Buge A; Rancurel G; Poisson M; Gazengel J; Dechy H; Fressinaud L; Emile J
    Ann Med Interne (Paris); 1974 Dec; 125(12):877-88. PubMed ID: 4469951
    [No Abstract]   [Full Text] [Related]  

  • 4. [Myoclonic encephalopathies induced by bismuth salts. 6 cases observed during long-term oral treatment].
    Buge A; Rancurel G; Poisson M; Dechy H
    Nouv Presse Med; 1974 Oct; 3(36):2315-20. PubMed ID: 4218313
    [No Abstract]   [Full Text] [Related]  

  • 5. [Letter: Reversible acute myoclonic encephalopathies after bismuth salt ingestion].
    Fressinaud L; Emile J; Charbonnel A; Féve JR
    Nouv Presse Med; 1975 Mar; 4(12):885. PubMed ID: 1136684
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reversible encephalopathies caused by bismuth salts. 5 further cases].
    Lhermitte F; Degos CF; Signoret JL
    Nouv Presse Med; 1975 Feb; 4(6):419-20. PubMed ID: 1129094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Poisoning by bismuth salts].
    Sanz Gallén P; Nogué Xarau S
    Med Clin (Barc); 1985 Apr; 84(13):538-41. PubMed ID: 3889518
    [No Abstract]   [Full Text] [Related]  

  • 8. Bismuth encephalopathy.
    Monseu G; Struelens M; Roland M
    Acta Neurol Belg; 1976; 76(5-6):301-8. PubMed ID: 1007897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research conducted by INSERM on myoclonic encephalopathies induced by the insoluble salts of bismuth used in gastroenterology].
    Olive G
    Therapie; 1980; 35(3):305-6. PubMed ID: 6775384
    [No Abstract]   [Full Text] [Related]  

  • 10. Bismuth toxicity in man II. Review of bismuth blood and urine levels in patients after administration of therapeutic bismuth formulations in relation to the problem of bismuth toxicity in man.
    Serfontein WJ; Mekel R
    Res Commun Chem Pathol Pharmacol; 1979 Nov; 26(2):391-411. PubMed ID: 392661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Letter: Encephalopathies due to insoluble salts of bismuth].
    Goule JP; Husson A; Fondimare A; Rapoport F; Lebreton M; Lajarige V
    Nouv Presse Med; 1975 May; 4(18):1366. PubMed ID: 1153303
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bismuth encephalopathy. A propos of 2 cases].
    Loutre JC; Viguié R; Kunstler E; Nehlil J
    Rev Neurol (Paris); 1975 Dec; 131(12):883-6. PubMed ID: 1232663
    [No Abstract]   [Full Text] [Related]  

  • 13. [Encephalopathy during oral treatment with bismuth salts].
    Michaud PA; Regli F
    Schweiz Med Wochenschr; 1976 Apr; 106(16):550-5. PubMed ID: 988634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Iatrogenic myoclonic encephalopathies caused by bismuth salts].
    Loiseau P; Henry P; Jallon P; Legroux M
    J Neurol Sci; 1976 Feb; 27(2):133-43. PubMed ID: 1249582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Letter: Myoclonic encephalopathies caused by bismuth salts].
    Tournilhac M; Flori B; Dordain G; Roye JM
    Nouv Presse Med; 1975 Feb; 4(6):430. PubMed ID: 1129100
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myoclonic encephalopathy due to bismuth salts. Negative search for an associated toxic element].
    Grandjean EM; Ducommun E; Gauthier G; Courvoisier B
    Schweiz Med Wochenschr; 1976 Jul; 106(30):1006-11. PubMed ID: 996522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bismuth toxicity in man - I. Bismuth blood and urine levels in patients after administration of a bismuth protein complex (Bicitropeptide).
    Serfontein WJ; Mekel R; Bank S; Barbezat G; Novis B
    Res Commun Chem Pathol Pharmacol; 1979 Nov; 26(2):383-9. PubMed ID: 523778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bismuth salts used in gastro-enterology. Data from animal investigations (author's transl)].
    Bouvet P
    Ann Pharm Fr; 1981 Feb; 38(5):447-54. PubMed ID: 7011157
    [No Abstract]   [Full Text] [Related]  

  • 19. [Letter: Encephalopathies during treatment with bismuth or the mishaps of"conjugated" bismuth therapy].
    Raverdy P; Smagghe A; Marie JP; Prinseau J
    Nouv Presse Med; 1975 Apr; 4(14):1050. PubMed ID: 805409
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tomodensitometric aspects of 3 cases of acute bismuth encephalopathy (author's transl)].
    Metzger J; Buge A; Rancurel G; Gardeur D
    Rev Neurol (Paris); 1978 Oct; 134(10):619-24. PubMed ID: 749121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.